Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-15 Sale | 2026-04-17 4:53 pm | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 218,600 | $4.0349 | $882,028 | 295,224 (Direct) | View |
| 2026-04-13 Sale | 2026-04-15 7:59 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 118,849 | $3.6 | $427,860 | 397,106 (Direct) | View |
| 2026-04-09 Sale | 2026-04-13 8:34 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 56,596 | $3.5537 | $201,124 | 515,955 (Direct) | View |
| 2026-04-09 Sale | 2026-04-10 6:46 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 14,500 | $3.38 | $49,010 | 518,622 (Direct) | View |
| 2026-04-06 Sale | 2026-04-08 8:32 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 260,427 | $3.4541 | $899,538 | 533,122 (Direct) | View |
| 2026-04-02 Sale | 2026-04-03 6:17 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 26,858 | $3.48 | $93,466 | 1,624,697 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:36 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 5,100 | $3.3096 | $16,879 | 77,079 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:36 pm | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2,594 | $3.3096 | $8,585 | 41,600 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:35 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 1,834 | $3.3096 | $6,070 | 216,019 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-15 Option Award(A) | 2026-09-18 4:45 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 236,952 | $0 | 236,952 (Direct) | View |
| 2026-09-15 Option Award(A) | 2026-09-18 4:44 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 183,266 | $0 | 183,266 (Direct) | View |
| 2026-09-15 Option Award(A) | 2026-09-18 4:43 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Dornan David Chief Scientific Officer | 171,774 | $0 | 171,774 (Direct) | View |
| 2026-09-15 Option Award(A) | 2026-09-18 4:41 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 387,914 | $0 | 387,914 (Direct) | View |
| 2026-09-15 Option Award(A) | 2026-09-18 4:40 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 162,500 | $0 | 162,500 (Direct) | View |
| 2026-09-15 Option Award | 2026-09-15 7:07 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 387,914 | $0 | 387,914 (Direct) | View |
| 2026-09-15 Option Award | 2026-09-15 7:07 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 236,952 | $0 | 236,952 (Direct) | View |
| 2026-09-15 Option Award | 2026-09-15 7:06 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 162,500 | $0 | 162,500 (Direct) | View |
| 2026-09-15 Option Award | 2026-09-15 7:05 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | Dornan David Chief Scientific Officer | 171,774 | $0 | 171,774 (Direct) | View |
| 2026-09-15 Option Award | 2026-09-15 7:05 pm | N/A 2036-09-15 | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 183,266 | $0 | 183,266 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-11 4:04 pm | N/A 2036-09-09 | Whitehawk Therapeutics Inc. | WHWK | Iyengar Vijay K Director | 76,080 | $0 | 76,080 (Direct) | View |
| 2026-06-12 Option Award | 2026-07-30 4:04 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Dalal Anupam Director | 38,040 | $0 | 4,725,082 (Direct) | View |
| 2026-05-14 Option Award | 2026-07-30 4:04 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Dalal Anupam Director | 1,275,510 | $3.92 | 4,725,082 (Indirect) | View |
| 2026-06-12 Option Award | 2026-06-15 5:27 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Zhao Baiteng Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:26 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Reeve Emma Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:24 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Maroun Richard E Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:23 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Hirmand Mohammad Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:22 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Desai Neil Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:21 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-15 5:18 pm | N/A 2036-06-12 | Whitehawk Therapeutics Inc. | WHWK | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See remarks 10% Owner | 38,040 | $0 | 38,040 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:06 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 19,132 | $3.92 | 19,132 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:05 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 51,020 | $3.92 | 448,126 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:04 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 38,265 | $3.92 | 333,489 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:03 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 51,021 | $3.92 | 569,643 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:02 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 255,102 | $3.92 | 4,513,550 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:02 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 2,072,756 | $8,124,996 | 4,513,550 (Indirect) | View |
| 2026-05-12 Option Award | 2026-05-14 7:40 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Avoro Capital Advisors LLC Aghazadeh Behzad Avoro Ventures LLC See Remarks 10% Owner | 6,377,714 | $3.9199 | 14,710,714 (Indirect) | View |
| 2026-04-01 Option Award | 2026-04-03 6:22 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Dornan David Chief Scientific Officer | 282,340 | $0 | 282,340 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:21 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 283,157 | $0 | 283,157 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:20 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 250,058 | $0 | 822,609 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:20 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 366,532 | $0 | 822,609 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:18 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 300,677 | $0 | 802,679 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:18 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 473,902 | $0 | 802,679 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:17 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 831,148 | $0 | 1,624,697 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:17 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 775,828 | $0 | 1,624,697 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:36 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 16,250 | $0 | 77,079 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:36 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 6,750 | $0 | 41,600 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:35 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 5,000 | $0 | 216,019 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-02 4:48 pm | N/A 2035-12-01 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 705,309 | $0 | 705,309 (Direct) | View |